Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT07216105 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 119 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Fate Therapeutics |
| Last Updated on CT.gov | September 2, 2026 (Sep 2, 2026) |
As of October 15, 2026: Clinical trial NCT07216105 is currently recruiting participants. This phase1 study for non-small cell lung cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Fate Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216105 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216105 was last updated Sep 2, 2026 (September 2, 2026). HelloStudys verifies this status automatically.